Lista de obras -

Activating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes

artículo científico publicado en 2018

Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition.

artículo científico publicado en 2016

Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy

artículo científico publicado en 2015

Breast cancer prevention: lessons to be learned from mechanisms of early pregnancy-mediated breast cancer protection

artículo científico publicado en 2015

CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases

artículo científico publicado en 2015

Can phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibition ERase them all? ⬇️

artículo científico publicado el 20 de octubre de 2010

Cancer cell redirection biomarker discovery using a mutual information approach

artículo científico publicado en 2017

Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion

artículo científico publicado en 2012

Complexity galore: 3D cultures, biomechanics and systems medicine at the eighth ENBDC workshop "Methods in Mammary Gland Development and Cancer".

artículo científico publicado en 2016

European Network of Breast Development and Cancer turned 10 years: a growing family of mammary gland researchers

article

Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R.

artículo científico publicado en 2013

Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes

artículo científico publicado en 2008

Glucocorticoids promote breast cancer metastasis

artículo científico publicado en 2019

Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.

artículo científico publicado en 2017

Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors ⬇️

artículo científico publicado el 11 de abril de 2011

MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation

artículo científico publicado en 2014

Mammary tumor formation and metastasis evoked by a HER2 splice variant

artículo científico publicado en 2013

Mechanism-based cancer therapy: resistance to therapy, therapy for resistance

artículo científico

Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

artículo científico publicado en 2016

RNA Expression Profiling Reveals Differentially Regulated Growth Factor and Receptor Expression in Redirected Cancer Cells

artículo científico publicado en 2017

SHP2 regulates proliferation and tumorigenicity of glioma stem cells.

artículo científico publicado en 2017

Stimulating translational research: several European life science institutions put their heads together.

artículo científico publicado en 2015

Tackling Resistance to PI3K Inhibition by Targeting the Epigenome

artículo científico publicado en 2017

Targeting PI3K, HER2 and the IL-8/JAK2 axis in metastatic breast cancer: Which combination makes the whole greater than the sum of its parts?

artículo científico publicado en 2013

Targeting protein-tyrosine phosphatases in breast cancer

artículo científico publicado en 2012

The Eleventh ENBDC Workshop: Advances in Technology Help to Unveil Mechanisms of Mammary Gland Development and Cancerogenesis

scientific article published on 07 September 2019

The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα

scientific journal article

The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells

artículo científico publicado en 2021

The devil is in the methods: lineage tracing, functional screens and sequencing, hormones, tumour-stroma interactions, and expansion of human breast tumours as xenografts ⬇️

artículo científico publicado el 14 de octubre de 2011

The ninth ENBDC Weggis meeting: growth and in-depth characterisation of normal and neoplastic breast cells.

artículo científico publicado en 2017

Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop

artículo científico publicado en 2012

VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation

artículo científico publicado en 2014

‘The charmingest place’: non-coding RNA, lineage tracing, tumor heterogeneity, metastasis and metabolism--new methods in mammary gland development and cancer: the fifth ENBDC Workshop

artículo científico publicado en 2013

Lista de obras de

Activating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes

Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition.

Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy

Breast cancer prevention: lessons to be learned from mechanisms of early pregnancy-mediated breast cancer protection

CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases

Can phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibition ERase them all? ⬇️

Cancer cell redirection biomarker discovery using a mutual information approach

Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion

Complexity galore: 3D cultures, biomechanics and systems medicine at the eighth ENBDC workshop "Methods in Mammary Gland Development and Cancer".

European Network of Breast Development and Cancer turned 10 years: a growing family of mammary gland researchers

Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R.

Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes

Glucocorticoids promote breast cancer metastasis

Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.

Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors ⬇️

MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation

Mammary tumor formation and metastasis evoked by a HER2 splice variant

Mechanism-based cancer therapy: resistance to therapy, therapy for resistance

Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

RNA Expression Profiling Reveals Differentially Regulated Growth Factor and Receptor Expression in Redirected Cancer Cells

SHP2 regulates proliferation and tumorigenicity of glioma stem cells.

Stimulating translational research: several European life science institutions put their heads together.

Tackling Resistance to PI3K Inhibition by Targeting the Epigenome

Targeting PI3K, HER2 and the IL-8/JAK2 axis in metastatic breast cancer: Which combination makes the whole greater than the sum of its parts?

Targeting protein-tyrosine phosphatases in breast cancer

The Eleventh ENBDC Workshop: Advances in Technology Help to Unveil Mechanisms of Mammary Gland Development and Cancerogenesis

The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα

The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells

The devil is in the methods: lineage tracing, functional screens and sequencing, hormones, tumour-stroma interactions, and expansion of human breast tumours as xenografts ⬇️

The ninth ENBDC Weggis meeting: growth and in-depth characterisation of normal and neoplastic breast cells.

Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop

VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation

‘The charmingest place’: non-coding RNA, lineage tracing, tumor heterogeneity, metastasis and metabolism--new methods in mammary gland development and cancer: the fifth ENBDC Workshop